Infection Surveillance and Selective Decontamination of the Digestive Tract (SDD) in Critically Ill Patients--results of a Controlled Study
Overview
Authors
Affiliations
All ICU patients were continuously monitored for infections according to a standard protocol by the physician in charge and an infection control nurse during the first quarter of five consecutive years (1980-1984). The number of patients surveyed was 1,009. The average age was 45.5 years and the average period of stay about four days. 733 patients (72.6%) were intubated and artificially ventilated for three days. A fatal outcome resulted in 13.2% of all patients, 1,129 nosocomial infections were registered in 331 patients, which means an infection rate of 32.8%. The most frequent nosocomial infections were those of the respiratory tract (24.3%). Wound infections developed in 16.6%. The urinary tract was affected in 8.8%. Nosocomial septicaemias were observed in 8.7%. Catheter-associated infections were found in 6.7% of the patients. A fatal outcome resulted in 26% of the patients with nosocomial infections and in 6.9% of the non-infected patients, respectively. There was no significant reduction in nosocomial infections over the five-year period in our ICU. Therefore, a study was designed to evaluate the concept of selective decontamination of the digestive tract (SDD) in critically ill patients in our two surgical/traumatological ICUs. A prospective, consecutive, placebo-controlled study in two ICUs was carried out during four six-month periods. 200 patients who were intubated for at least three days, required intensive care for a minimum of five days, and belonged to either class III or IV according to the "Therapeutic Intervention Scoring System" were included in the study. They received either placebo or a prophylaxis regimen, consisting of polymyxin E, tobramycin and amphotericin B.(ABSTRACT TRUNCATED AT 250 WORDS)
Hurley J Antibiotics (Basel). 2024; 13(4).
PMID: 38666992 PMC: 11047347. DOI: 10.3390/antibiotics13040316.
van Till J, van Ruler O, Lamme B, Weber R, Reitsma J, Boermeester M Crit Care. 2007; 11(6):R126.
PMID: 18067657 PMC: 2246222. DOI: 10.1186/cc6191.
Tissot van Patot H, Leusink J, Roodenburg J, de Jongh B, Lau H, de Boer S Pharm World Sci. 1996; 18(5):171-7.
PMID: 8933577 DOI: 10.1007/BF00820728.
Gorman S, Adair C, ONeill F, Goldsmith C, Webb H Eur J Clin Microbiol Infect Dis. 1993; 12(1):9-17.
PMID: 8462571 DOI: 10.1007/BF01997050.
Selective digestive decontamination by erythromycin-base in a polyvalent intensive care unit.
de Champs C, Guelon D, Garnier R, Poupart M, Mansoor O, Dissait F Intensive Care Med. 1993; 19(4):191-6.
PMID: 8366226 DOI: 10.1007/BF01694769.